The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy
Status:
Withdrawn
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This is a single-arm, open label safety and dose titration study evaluating the use of
Clevidipine to rapidly control elevated blood pressure in patients who have an Intracranial
Pressure Monitoring device.